Somewhat Positive Press Coverage Somewhat Unlikely to Impact U.S. Physical Therapy (USPH) Share Price
Media coverage about U.S. Physical Therapy (NYSE:USPH) has trended somewhat positive on Friday, according to Accern Sentiment. Accern scores the sentiment of news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. U.S. Physical Therapy earned a media sentiment score of 0.20 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 46.682352450134 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
These are some of the media stories that may have impacted Accern’s scoring:
- U.S. Physical Therapy Announces Impact to Operations from Hurricanes Harvey and Irma (finance.yahoo.com)
- U.S. Physical Therapy, Inc. breached its 50 day moving average in a Bullish Manner : USPH-US : September 28, 2017 (finance.yahoo.com)
- U.S. Physical Therapy, Inc. :USPH-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017 (finance.yahoo.com)
- ETFs with exposure to U.S. Physical Therapy, Inc. : October 2, 2017 (finance.yahoo.com)
Several analysts have recently issued reports on the stock. BidaskClub upgraded shares of U.S. Physical Therapy from a “strong sell” rating to a “sell” rating in a research report on Thursday, September 28th. Cantor Fitzgerald assumed coverage on shares of U.S. Physical Therapy in a research report on Monday, July 24th. They set an “overweight” rating and a $72.00 target price on the stock. Zacks Investment Research upgraded shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $64.00 target price on the stock in a research report on Tuesday, August 29th. Jefferies Group LLC set a $65.00 target price on shares of U.S. Physical Therapy and gave the company a “hold” rating in a research report on Friday, August 4th. Finally, Sidoti upgraded shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and upped their target price for the company from $62.00 to $74.00 in a research report on Friday, September 8th. One research analyst has rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $68.60.
Shares of U.S. Physical Therapy (USPH) traded down 0.08% during mid-day trading on Friday, hitting $63.80. 1,561 shares of the stock traded hands. The company has a market cap of $802.67 million, a P/E ratio of 40.38 and a beta of 1.06. U.S. Physical Therapy has a 12 month low of $51.96 and a 12 month high of $78.00. The firm has a 50 day moving average of $59.67 and a 200 day moving average of $62.59.
U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Thursday, August 3rd. The company reported $0.59 earnings per share for the quarter, missing analysts’ consensus estimates of $0.60 by ($0.01). The business had revenue of $104.25 million for the quarter, compared to analyst estimates of $102.93 million. U.S. Physical Therapy had a return on equity of 12.91% and a net margin of 5.65%. Equities analysts anticipate that U.S. Physical Therapy will post $2.12 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Friday, September 8th. Investors of record on Monday, August 21st were given a dividend of $0.20 per share. The ex-dividend date was Thursday, August 17th. This represents a $0.80 dividend on an annualized basis and a yield of 1.25%. U.S. Physical Therapy’s payout ratio is presently 46.78%.
In other U.S. Physical Therapy news, COO Glenn Mcdowell sold 2,598 shares of U.S. Physical Therapy stock in a transaction dated Wednesday, August 30th. The shares were sold at an average price of $57.00, for a total transaction of $148,086.00. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Bernard A. Harris, Jr. sold 5,000 shares of U.S. Physical Therapy stock in a transaction dated Thursday, August 10th. The stock was sold at an average price of $62.00, for a total transaction of $310,000.00. Following the transaction, the director now directly owns 26,422 shares in the company, valued at $1,638,164. The disclosure for this sale can be found here. Insiders have sold 13,266 shares of company stock worth $801,134 over the last 90 days. 3.10% of the stock is currently owned by company insiders.
TRADEMARK VIOLATION NOTICE: This news story was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another site, it was copied illegally and reposted in violation of United States & international copyright & trademark legislation. The original version of this news story can be viewed at https://www.watchlistnews.com/somewhat-positive-press-coverage-somewhat-unlikely-to-impact-u-s-physical-therapy-usph-share-price/1612643.html.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.
Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.